This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
bacteria:t3e:xopj7 [2025/07/24 09:44] – created rkoebnik | bacteria:t3e:xopj7 [2025/07/24 23:28] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | bla bla | + | ====== The Type III Effector XopJ7 from // |
+ | |||
+ | Author: Anna Passelergue\\ | ||
+ | Internal reviewer: [[https:// | ||
+ | |||
+ | Class: XopJ\\ | ||
+ | Family: XopJ7\\ | ||
+ | Prototype: E4A48_06420 (// | ||
+ | GenBank ID: [[https:// | ||
+ | RefSeq ID: [[https:// | ||
+ | 3D structure: Unknown | ||
+ | |||
+ | ===== Biological function ===== | ||
+ | |||
+ | === How discovered? === | ||
+ | |||
+ | XopJ7 was discovered as an ORF that is encoded downstream of a PIP box and a properly spaced ‐10 promoter motif (TTCGB‐N< | ||
+ | |||
+ | === (Experimental) evidence for being a T3E === | ||
+ | |||
+ | XopJ7 was shown to have a functional type III secretion signal using a reporter fusion with AvrBs1 (Zhao //et al.//, 2013). | ||
+ | |||
+ | === Regulation === | ||
+ | |||
+ | The presence of a PIP box and a properly spaced ‐10 promoter motif (TTCGB‐N< | ||
+ | |||
+ | === Phenotypes === | ||
+ | |||
+ | Unknown. | ||
+ | |||
+ | === Localization === | ||
+ | |||
+ | The presence of conserved myristoylation and palmitoylation signals at the N terminus suggests that the protein is localized to the plasma membrane in the plant host cell (Nimchuk //et al.//, 2000; Thieme //et al.//, 2007). | ||
+ | === Enzymatic function === | ||
+ | |||
+ | Unknown. | ||
+ | |||
+ | === Interaction partners === | ||
+ | |||
+ | Unknown. | ||
+ | |||
+ | ===== Conservation ===== | ||
+ | |||
+ | === In xanthomonads === | ||
+ | |||
+ | Yes (//e.g.//, //X. euvesicatoria//, | ||
+ | = | ||
+ | == In other plant pathogens/ | ||
+ | |||
+ | Yes (e.g., // | ||
+ | |||
+ | ===== References ===== | ||
+ | |||
+ | Koebnik R, Krüger A, Thieme F, Urban A, Bonas U (2006). Specific binding of the // | ||
+ | |||
+ | Nimchuk Z, Marois E, Kjemtrup S, Leister RT, Katagiri F, Dangl JL (2000). Eukaryotic fatty acylation drives plasma membrane targeting and enhances function of several type III effector proteins from // | ||
+ | |||
+ | Passelergue A (2025). Discovery of eight type III effector genes harboring the PIP box in clade-I xanthomonads. Master' | ||
+ | |||
+ | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | ||
+ | |||
+ | Wengelnik K, Bonas U (1996). HrpXv, an AraC-type regulator, activates expression of five of the six loci in the hrp cluster of // | ||
+ | |||
+ | Wengelnik K, Van den Ackerveken G, Bonas U (1996). HrpG, a key hrp regulatory protein of // | ||
+ | |||
+ | Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL effectors in // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||